Physician

Jonathan Amir Feistmann, MD

According to 2025 Medicare claims, Jonathan Feistmann, MD (NPI: 1447331087) practices ophthalmology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Queens, NY. This provider's primary affiliated billing organization is JONATHAN A. FEISTMANN, MD PC (NPI: 1619112943; TIN: 263836070) and primary practice location at 10003-5944.

Feistmann's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 722 traditional Medicare patients, billed 55,569 HCPCS/CPT codes, and received $3,008,488 in Medicare payments. The top billing code was 92273 (Measurement of retinal and optic nerve function). Part D data shows 530 prescription claims across 122 beneficiaries totaling $43,036 in drug costs, led by Prolensa (Bromfenac Sodium). Open Payments data shows 30 records totaling $21,255. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $158,543 to $3,008,488. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.5M$3.0M2015 Medicare payment: $158,543 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $209,550 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $176,675 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $327,412 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $520,448 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,143,107 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,193,323 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,578,982 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,730,608 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,008,488 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20153361,531$158,543
20163982,116$209,550
20173712,090$176,675
20184313,167$327,412
20195323,737$520,448
20205335,185$1,143,107
20216027,973$2,193,323
202276710,548$2,578,982
202385929,527$2,730,608
202472255,569$3,008,488

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$57K$114K2015 Drug cost: $24,302 (USD; Tot_Drug_Cst)2016 Drug cost: $30,307 (USD; Tot_Drug_Cst)2017 Drug cost: $75,646 (USD; Tot_Drug_Cst)2018 Drug cost: $64,430 (USD; Tot_Drug_Cst)2019 Drug cost: $67,828 (USD; Tot_Drug_Cst)2020 Drug cost: $113,771 (USD; Tot_Drug_Cst)2021 Drug cost: $92,491 (USD; Tot_Drug_Cst)2022 Drug cost: $77,627 (USD; Tot_Drug_Cst)2023 Drug cost: $72,900 (USD; Tot_Drug_Cst)2024 Drug cost: $43,036 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201558228$24,302
201687359$30,307
2017104418$75,646
2018119501$64,430
2019147650$67,828
2020134551$113,771
2021169698$92,491
2022170749$77,627
2023138652$72,900
2024122530$43,036

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92273Measurement of retinal and optic nerve function336429$112
92014Established patient complete exam of visual system6011,335$104
67028Injection of drug into eye1901,372$101
92134Imaging of retina7082,104$35
92202Extended exam of the back part of the eye with optic nerve drawing509773$13

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ProlensaBromfenac Sodium371,433$15,893
Bromfenac SodiumBromfenac Sodium481,696$6,320
Prednisolone AcetatePrednisolone Acetate984,888$5,265
DifluprednateDifluprednate22638$1,329
OfloxacinOfloxacin391,450$800

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.30$21,255Carl Zeiss Meditec, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jonathan Amir Feistmann, MD?

Tedicare shows public-source Medicare data for Jonathan Amir Feistmann, MD (NPI 1447331087), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jonathan Amir Feistmann, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jonathan Amir Feistmann, MD?

Jonathan Amir Feistmann, MD is linked to JONATHAN A. FEISTMANN, MD PC (billing NPI 1619112943) in the available physician profile data.

Does Jonathan Amir Feistmann, MD have Open Payments data?

Jonathan Amir Feistmann, MD has 30 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.